| scholarly article | Q13442814 |
| P2093 | author name string | Gang Chen | |
| Kang Liu | |||
| Jixi Li | |||
| Tingting Zhang | |||
| Zhendong Yang | |||
| Min Kang | |||
| Rensheng Wang | |||
| P2860 | cites work | Gene ontology: tool for the unification of biology | Q23781406 |
| AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas | Q24336818 | ||
| The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 | Q24617130 | ||
| miR-34a repression of SIRT1 regulates apoptosis | Q24652720 | ||
| MicroRNA profiling: approaches and considerations | Q26861675 | ||
| miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. | Q53306726 | ||
| miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. | Q53388648 | ||
| Detection of miR-34a and miR-34b/c in stool sample as potential screening biomarkers for noninvasive diagnosis of colorectal cancer | Q87366552 | ||
| Head and Neck Cancer | Q89434036 | ||
| Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study | Q95504652 | ||
| The miR-34 family in cancer and apoptosis | Q28245865 | ||
| Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer | Q28291502 | ||
| Mutational landscape and significance across 12 major cancer types | Q28300353 | ||
| Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells | Q28476781 | ||
| KEGG for integration and interpretation of large-scale molecular data sets | Q29547277 | ||
| Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis | Q29547575 | ||
| MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells | Q33497932 | ||
| Frequent downregulation of miR-34 family in human ovarian cancers | Q33658229 | ||
| MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer | Q34079217 | ||
| MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo | Q34211970 | ||
| miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions | Q34237504 | ||
| Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis | Q34282049 | ||
| MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame | Q34369223 | ||
| p53 enters the microRNA world | Q36998341 | ||
| The p53 Pathway Encounters the MicroRNA World | Q37625833 | ||
| MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy | Q37660733 | ||
| The molecular biology of head and neck cancer | Q37821229 | ||
| New insights into p53 functions through its target microRNAs | Q38205171 | ||
| MicroRNAs in cancer: biomarkers, functions and therapy | Q38229952 | ||
| UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. | Q38667837 | ||
| A Human Head and Neck Squamous Cell Carcinoma Cell Line with Acquired cis-Diamminedichloroplatinum-Resistance Shows Remarkable Upregulation of BRCA1 and Hypersensitivity to Taxane | Q38791316 | ||
| Unpredictable changes of selected miRNA in expression profile of HNSCC. | Q38951652 | ||
| MicroRNA‑34a/c function as tumor suppressors in Hep‑2 laryngeal carcinoma cells and may reduce GALNT7 expression | Q39028624 | ||
| Dysregulation of microRNA-34a expression in colorectal cancer inhibits the phosphorylation of FAK via VEGF. | Q39039614 | ||
| Expression and role of miR-34a in bladder cancer | Q39145836 | ||
| Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway | Q39204898 | ||
| MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. | Q39343253 | ||
| Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells | Q39375782 | ||
| CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome | Q39491554 | ||
| miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells | Q39917469 | ||
| A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene | Q39978280 | ||
| p53-mediated activation of miRNA34 candidate tumor-suppressor genes. | Q40102003 | ||
| CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker | Q40488508 | ||
| MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers. | Q44463289 | ||
| miRWalk2.0: a comprehensive atlas of microRNA-target interactions | Q46692723 | ||
| LinkedOmics: analyzing multi-omics data within and across 32 cancer types | Q47106278 | ||
| Expression Analysis of Liver-Specific Circulating microRNAs in HCV-Induced Hepatocellular Carcinoma in Egyptian Patients | Q47553678 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bioinformatics | Q128570 |
| head and neck squamous cell carcinoma | Q18348812 | ||
| P304 | page(s) | 2246-2263 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | American Journal of Translational Research | Q4744272 |
| P1476 | title | A comprehensive investigation using meta-analysis and bioinformatics on miR-34a-5p expression and its potential role in head and neck squamous cell carcinoma | |
| P478 | volume | 10 |
Search more.